Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LifeMD, Inc.LFMD · Entity 6521 | Director | May 04, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LifeMD, Inc.
Report date May 04, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 498,001 |
Ending reported balance
After 2026-08-11 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-04 · Grant · Acquired 50,000 · Balance 463,001 F1: The grant of restricted shares vests immediately. Row 2 · 2026-08-11 · Grant · Acquired 35,000 · Balance 498,001 F2: The grant of restricted shares vests on June 1, 2027. |
| Common StockSEC Table I · non-derivative | IndirectStrawn Pickens LLP | 60,000 |
Reported balance
Holding disclosure · report date 2026-05-04 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 60,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The grant of restricted shares vests immediately.
F2: The grant of restricted shares vests on June 1, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2026 Filed Aug 18, 2026 20:51 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-26-001125 · form4.xml · nonDerivative · entry 2 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 498,001 F2 · shares: The grant of restricted shares vests on June 1, 2027. Read SEC document |
| May 04, 2026 Filed Aug 18, 2026 20:51 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-26-001125 · form4.xml · nonDerivative · entry 1 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 463,001 F1 · shares: The grant of restricted shares vests immediately. Read SEC document |
| October 06, 2025 Filed Oct 8, 2025 22:25 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 22,365 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-001050 · form4.xml · nonDerivative · entry 1 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 413,001 F1 · shares: The grant of restricted shares vests on June 1, 2026. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 13:14 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 24,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-048806 · ownership.xml · nonDerivative · entry 3 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,636 F3 · shares: The grant of restricted shares vests on June 1, 2025. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 13:14 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 2,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-048806 · ownership.xml · nonDerivative · entry 2 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,988 F2 · shares: The grant of restricted shares vests immediately. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 13:14 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-048806 · ownership.xml · nonDerivative · entry 1 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,347 F1 · shares: The grant of restricted shares vests on December 2, 2024. Read SEC document |
| August 25, 2023 Filed Aug 29, 2023 20:33 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-030544 · ownership.xml · nonDerivative · entry 3 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,347 F3 · price: The grant of restricted shares vests immediately. Read SEC document |
| November 22, 2022 Filed Aug 29, 2023 20:33 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-030544 · ownership.xml · nonDerivative · entry 2 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,347 F2 · price: The grant of restricted shares vested incrementally on December 31, 2022 (50%); March 31, 2023 (25%); and June 16, 2023 (25%). Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 19:31 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantRestricted Stock Unit · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001362118-21-000034 · primary_doc.xml · derivative · entry 3 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs vest quarterly with 25% vesting on September 30, 2021, December 31, 2021, March 31, 2022 and on the earlier of the annual stockholders' meeting or June 30, 2022. F1 · derivative.exercise_date: The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs vest quarterly with 25% vesting on September 30, 2021, December 31, 2021, March 31, 2022 and on the earlier of the annual stockholders' meeting or June 30, 2022. F1 · derivative.expiration_date: The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs vest quarterly with 25% vesting on September 30, 2021, December 31, 2021, March 31, 2022 and on the earlier of the annual stockholders' meeting or June 30, 2022. Read SEC document |
| September 07, 2021 Filed Aug 29, 2023 20:33 UTC | LifeMD, Inc. LFMD · Entity 6521 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-030544 · ownership.xml · nonDerivative · entry 1 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,347 F1 · price: This grant of restricted shares was previously reported on Table II of a Form 4 dated September 8, 2021. The shares vested incrementally on September 30, 2021 (25%); December 31, 2021 (25%); March 31, 2022 (25%); and June 16, 2022 (25%). Read SEC document |
| April 18, 2021 Filed Apr 22, 2021 22:02 UTC | LifeMD, Inc. LFMD · Entity 6521 | Exercise / conversionOption · Derivative | 100,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001362118-21-000003 · primary_doc.xml · derivative · entry 7 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 · 100,000 shares Expires 2021-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.underlying_shares: The original grant of 500,000 common stock options was subject to a 1-for-5 reverse stock split in October, 2020. The exercise reported herein is the shares remaining after the split. Read SEC document |
| April 18, 2021 Filed Apr 22, 2021 22:02 UTC | LifeMD, Inc. LFMD · Entity 6521 | Exercise / conversionOption · Derivative | 200,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001362118-21-000003 · primary_doc.xml · derivative · entry 6 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 · 200,000 shares Expires 2021-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.underlying_shares: The original grant of 1,000,000 common stock options was subject to a 1-for-5 reverse stock split in October, 2020. The exercise reported herein is the shares remaining after the split. Read SEC document |
| April 18, 2021 Filed Apr 22, 2021 22:02 UTC | LifeMD, Inc. LFMD · Entity 6521 | Tax withholdingCommon Stock, par value $0.01 | 20,060 | $9.97 | $199,998.20 |
DisclosureSEC source: 0001362118-21-000003 · primary_doc.xml · nonDerivative · entry 4 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,347 F3 · shares: Reflects 20,060 shares withheld by issuer to fund the cashless exercise of 100,000 options pursuant to the Reporting Person's Stock Option Agreement. Read SEC document |
| April 18, 2021 Filed Apr 22, 2021 22:02 UTC | LifeMD, Inc. LFMD · Entity 6521 | Exercise / conversionCommon Stock, par value $0.01 | 100,000 | $2.00 | $200,000.00 |
DisclosureSEC source: 0001362118-21-000003 · primary_doc.xml · nonDerivative · entry 3 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 18, 2021 Filed Apr 22, 2021 22:02 UTC | LifeMD, Inc. LFMD · Entity 6521 | Tax withholdingCommon Stock, par value $0.01 | 20,060 | $9.97 | $199,998.20 |
DisclosureSEC source: 0001362118-21-000003 · primary_doc.xml · nonDerivative · entry 2 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,407 F2 · shares: Reflects 20,060 shares withheld by issuer to fund the cashless exercise of 200,000 options pursuant to the Reporting Person's Stock Option Agreement. Read SEC document |
| April 18, 2021 Filed Apr 22, 2021 22:02 UTC | LifeMD, Inc. LFMD · Entity 6521 | Exercise / conversionCommon Stock, par value $0.01 | 200,000 | $1.00 | $200,000.00 |
DisclosureSEC source: 0001362118-21-000003 · primary_doc.xml · nonDerivative · entry 1 Strawn John R Jr · CIK 0001721394 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The Amount of Securities Beneficially Owned reflects a correction of an additional 467 shares from previous Form 3/A filing of the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.